FDA sends out cease and desist letters
Jan 23, 2008
The FDA recently sent warning letters out to over 25 veterinary pharmacies involved in the illegal resale of compounded Phenylbutazone powder. Citing the recent approval of SUPERIORBUTE® POWDER's drug application, the FDA's division of compliance notifies these pharmacies that compounding flavored phenylbutazone powder is "a violation of the Federal Food, Drug, and Cosmetic Act" and warns "if your firm has not already done so, your firm should immediately cease the compounding and sales of these illegal phenylbutazone products."
A copy of each letter was also sent to the Executive Director of the local Board Of Pharmacy in the state where the pharmacy is located.
SUPERIORBUTE® POWDER at AAEP
Nov 25, 2007
If you'll be at the AAEP's annual convention this weekend in Orlando Florida stop by our booth (#1638) to enter our drawing for free round trip airfare for two to Puerto Vallarta Mexico and a week's stay in a condo at Paradise Village!
SUPERIORBUTE® POWDER wins FDA Approval
May 15, 2007
We're proud to announce that after many years of hard work the FDA has finally approved SUPERIORBUTE® POWDER. The FDA registered ANADA number is #200-333. We have already begun arranging manufacturing and will soon be sending free samples and selling bottles to licensed veterinarians.
Update: The approval was officially announced in today's Federal Register. Can you tell the FDA is as excited as we are?